{"id":"https://openalex.org/W2018349136","doi":"https://doi.org/10.1016/j.jval.2014.12.008","title":"Which Factors Enhance Positive Drug Reimbursement Recommendation in Scotland? A Retrospective Analysis 2006\u20132013","display_name":"Which Factors Enhance Positive Drug Reimbursement Recommendation in Scotland? A Retrospective Analysis 2006\u20132013","publication_year":2015,"publication_date":"2015-02-04","ids":{"openalex":"https://openalex.org/W2018349136","doi":"https://doi.org/10.1016/j.jval.2014.12.008","mag":"2018349136","pmid":"https://pubmed.ncbi.nlm.nih.gov/25773564"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2014.12.008","doi":"https://doi.org/10.1016/j.jval.2014.12.008","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2014.12.008","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301514047949/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.valueinhealthjournal.com/article/S1098301514047949/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113828454","display_name":"Mata Charokopou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094451","display_name":"Pharmerit (Netherlands)","ror":"https://ror.org/00ntr9f13","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210094451","https://openalex.org/I4210134090"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Mata Charokopou","raw_affiliation_strings":["Pharmerit BV, Rotterdam, The Netherlands. Electronic address: mcharokopou@pharmerit.com","Pharmerit BV, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmerit BV, Rotterdam, The Netherlands. Electronic address: mcharokopou@pharmerit.com","institution_ids":["https://openalex.org/I4210094451"]},{"raw_affiliation_string":"Pharmerit BV, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4210094451"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111925936","display_name":"Istvan Matyas Majer","orcid":"https://orcid.org/0009-0006-0522-4961","observed_orcids":["https://orcid.org/0009-0006-0522-4961"]},"institutions":[{"id":"https://openalex.org/I4210094451","display_name":"Pharmerit (Netherlands)","ror":"https://ror.org/00ntr9f13","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210094451","https://openalex.org/I4210134090"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Istvan M. Majer","raw_affiliation_strings":["Pharmerit BV, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmerit BV, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4210094451"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019737970","display_name":"Johan de Raad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094451","display_name":"Pharmerit (Netherlands)","ror":"https://ror.org/00ntr9f13","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210094451","https://openalex.org/I4210134090"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Johan de Raad","raw_affiliation_strings":["Pharmerit BV, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmerit BV, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4210094451"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018398541","display_name":"Stefan Broekhuizen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094451","display_name":"Pharmerit (Netherlands)","ror":"https://ror.org/00ntr9f13","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210094451","https://openalex.org/I4210134090"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Stefan Broekhuizen","raw_affiliation_strings":["Pharmerit BV, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmerit BV, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4210094451"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016565734","display_name":"Maarten Jacobus Postma","orcid":"https://orcid.org/0000-0002-6306-3653","observed_orcids":["https://orcid.org/0000-0002-6306-3653"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Maarten Postma","raw_affiliation_strings":["Unit of PharmacoEpidemiology & Pharmacoeconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of PharmacoEpidemiology & Pharmacoeconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039926945","display_name":"Bart M. S. Heeg","orcid":"https://orcid.org/0000-0002-9226-3232","observed_orcids":["https://orcid.org/0000-0002-9226-3232"]},"institutions":[{"id":"https://openalex.org/I4210094451","display_name":"Pharmerit (Netherlands)","ror":"https://ror.org/00ntr9f13","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210094451","https://openalex.org/I4210134090"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Bart Heeg","raw_affiliation_strings":["Pharmerit BV, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmerit BV, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4210094451"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5113828454"],"corresponding_institution_ids":["https://openalex.org/I4210094451"],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":{"value":4000,"currency":"USD","value_usd":4000},"fwci":10.8581,"has_fulltext":true,"cited_by_count":37,"citation_normalized_percentile":{"value":0.97938299,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"18","issue":"2","first_page":"284","last_page":"291"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9208999872207642,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9208999872207642,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.07680000364780426,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13896","display_name":"Health Services Management and Policy","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-reimbursement","display_name":"drug reimbursement","score":0.6470000147819519},{"id":"https://openalex.org/keywords/scottish-medicines-consortium","display_name":"Scottish Medicines Consortium","score":0.8080000281333923},{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.8370000123977661},{"id":"https://openalex.org/keywords/cost-effectiveness-analysis","display_name":"cost-effectiveness analysis","score":0.7200000286102295},{"id":"https://openalex.org/keywords/cost-minimization-analysis","display_name":"cost-minimization analysis","score":0.8880000114440918},{"id":"https://openalex.org/keywords/incremental-cost-effectiveness-ratio","display_name":"incremental cost-effectiveness ratio","score":0.875},{"id":"https://openalex.org/keywords/decision-factors","display_name":"decision factors","score":0.37700000405311584},{"id":"https://openalex.org/keywords/neurological-disorders","display_name":"neurological disorders","score":0.7179999947547913},{"id":"https://openalex.org/keywords/pharmaceutical-industry-influence","display_name":"pharmaceutical industry influence","score":0.4690000116825104}],"concepts":[{"id":"https://openalex.org/C199163554","wikidata":"https://www.wikidata.org/wiki/Q1681619","display_name":"Univariate","level":3,"score":0.779545783996582},{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.6601738929748535},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.5900900959968567},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5321015119552612},{"id":"https://openalex.org/C161584116","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate statistics","level":2,"score":0.5073115229606628},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.4708050489425659},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4566231966018677},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.45554083585739136},{"id":"https://openalex.org/C143095724","wikidata":"https://www.wikidata.org/wiki/Q515895","display_name":"Odds","level":3,"score":0.4481123387813568},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.42006492614746094},{"id":"https://openalex.org/C27574286","wikidata":"https://www.wikidata.org/wiki/Q320723","display_name":"Variables","level":2,"score":0.41214677691459656},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3596586287021637},{"id":"https://openalex.org/C21547014","wikidata":"https://www.wikidata.org/wiki/Q1423657","display_name":"Operations management","level":1,"score":0.3305499255657196},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.25234878063201904},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.22346791625022888},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.18251386284828186},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1162022054195404},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.11298823356628418},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.1008530855178833},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D006287","descriptor_name":"Health Planning Guidelines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009313","descriptor_name":"National Health Programs","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012606","descriptor_name":"Scotland","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013673","descriptor_name":"Technology Assessment, Biomedical","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D013673","descriptor_name":"Technology Assessment, Biomedical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D018588","descriptor_name":"Fee-for-Service Plans","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1016/j.jval.2014.12.008","doi":"https://doi.org/10.1016/j.jval.2014.12.008","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2014.12.008","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301514047949/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},{"id":"pmid:25773564","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25773564","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research","raw_type":"Journal Article"},{"id":"pmh:oai:pure.rug.nl:openaire/70530036-c7ab-4a2e-a0ef-5789541bcd98","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/70530036-c7ab-4a2e-a0ef-5789541bcd98","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Charokopou, M, Majer, I M, Raad, J D, Broekhuizen, S, Postma, M & Heeg, B 2015, 'Which Factors Enhance Positive Drug Reimbursement Recommendation in Scotland? A retrospective analysis 2006-2013', Value in Health, vol. 18, no. 2, pp. 284-291. https://doi.org/10.1016/j.jval.2014.12.008","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.rug.nl:openaire/6281f749-195b-4309-b849-5c36616cce8a","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/6281f749-195b-4309-b849-5c36616cce8a","pdf_url":"https://research.rug.nl/files/19289579/Title_and_contents.pdf","source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Heeg, B M S 2015, 'Developing health economic models of chronic diseases for reimbursement purposes', Doctor of Philosophy, University of Groningen, [Groningen]. https://doi.org/10.1016/j.jval.2014.12.008","raw_type":"info:eu-repo/semantics/doctoralThesis"},{"id":"pmh:rug:oai:pure.rug.nl:publications/6281f749-195b-4309-b849-5c36616cce8a","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/6281f749-195b-4309-b849-5c36616cce8a","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/doctoralthesis"},{"id":"pmh:rug:oai:pure.rug.nl:publications/70530036-c7ab-4a2e-a0ef-5789541bcd98","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/70530036-c7ab-4a2e-a0ef-5789541bcd98","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Value in Health, 18(2), 284 - 291. ELSEVIER SCIENCE INC","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2014.12.008","doi":"https://doi.org/10.1016/j.jval.2014.12.008","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2014.12.008","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301514047949/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2018349136.pdf","grobid_xml":"https://content.openalex.org/works/W2018349136.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1595046345","https://openalex.org/W1983744580","https://openalex.org/W1991285311","https://openalex.org/W1995571140","https://openalex.org/W2020460752","https://openalex.org/W2023338191","https://openalex.org/W2044771513","https://openalex.org/W2046917612","https://openalex.org/W2055136997","https://openalex.org/W2057137338","https://openalex.org/W2066807395","https://openalex.org/W2078764139","https://openalex.org/W2082192517","https://openalex.org/W2117042820","https://openalex.org/W2119939498","https://openalex.org/W2139255537","https://openalex.org/W2144658585","https://openalex.org/W2151985805","https://openalex.org/W2155508065","https://openalex.org/W2163036387","https://openalex.org/W2168123392","https://openalex.org/W2977025277"],"related_works":["https://openalex.org/W2053852539","https://openalex.org/W2324374637","https://openalex.org/W2995339383","https://openalex.org/W2544705996","https://openalex.org/W1816354307","https://openalex.org/W1546024690","https://openalex.org/W2898149259","https://openalex.org/W2344182883","https://openalex.org/W2127197903","https://openalex.org/W2150420236"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"identify":[2],"the":[3,7,22,63,82,91,95,130,147,154,159,171,196,208,236,252,262],"factors":[4,47],"that":[5,125,161,251],"influence":[6],"Scottish":[8,23],"Medicines":[9],"Consortium":[10],"(SMC)":[11],"in":[12,146],"deciding":[13],"whether":[14,207,224,235],"to":[15,65,80,141,212],"accept":[16],"pharmaceutical":[17],"technologies":[18],"for":[19,67,106,115,216,228],"use":[20,107,116,230],"within":[21,117],"health":[24,51],"care":[25],"system.":[26],"METHODS:":[27],"A":[28,55],"database":[29],"of":[30,42,86,90,100,151,156,254],"SMC":[31,131],"submissions":[32],"between":[33],"2006":[34],"and":[35,45,75,109,178,234],"2013":[36],"was":[37,59,164,170,195,210,226,238],"created,":[38],"containing":[39],"a":[40,72,143,162,167,179,182,213,217,241],"range":[41],"clinical,":[43],"economic,":[44],"other":[46,204],"extracted":[48],"from":[49],"published":[50],"technology":[52],"assessment":[53],"reports.":[54],"binomial":[56],"outcome":[57,155,253],"variable":[58,174],"used,":[60],"defined":[61],"as":[62],"decision":[64],"\"accept":[66],"use\"":[68],"or":[69],"\"not":[70],"recommend\"":[71],"technology.":[73],"Univariate":[74,122],"multivariate":[76,148],"analyses":[77,123,256],"were":[78,104,112,139],"conducted":[79],"assess":[81],"impact":[83,145],"by":[84,166,240],"means":[85],"odds":[87],"ratios":[88],"(ORs)":[89],"submitted":[92],"evidence":[93],"on":[94],"recommendation":[96,265],"decision.":[97,132,266],"RESULTS:":[98],"Out":[99],"463":[101],"applications,":[102],"265":[103],"accepted":[105],"(57%)":[108],"198":[110],"(43%)":[111],"not":[113,184],"recommended":[114],"National":[118],"Health":[119],"Service":[120],"Scotland.":[121],"showed":[124],"13":[126,135],"variables":[127,138,205],"significantly":[128],"affected":[129],"Of":[133],"these":[134,152],"variables,":[136],"7":[137],"shown":[140],"have":[142],"meaningful":[144],"analysis.":[149],"Four":[150],"concerned":[153,206],"cost-effectiveness":[157,189,255],"analyses;":[158],"fact":[160],"submission":[163,180,209,237],"supported":[165],"cost-minimization":[168],"analysis":[169],"strongest":[172,197],"positive":[173],"(OR":[175,200,221,231,244],"=":[176,201,222,232,245],"10.30)":[177],"showing":[181],"product":[183,214],"being":[185],"cost-effective":[186],"(i.e.,":[187],"incremental":[188],"ratio":[190],"above":[191],"\u00a330,000/quality-adjusted":[192],"life-year":[193],"gained)":[194],"negative":[198],"predictor":[199],"0.47).":[202],"The":[203],"related":[211],"indicated":[215,227],"nervous":[218],"system":[219],"disease":[220],"0.41),":[223],"it":[225],"nonchronic":[229],"1.66),":[233],"performed":[239],"big":[242],"company":[243],"2.83).":[246],"CONCLUSIONS:":[247],"This":[248],"study":[249],"demonstrated":[250],"is":[257],"an":[258],"important":[259],"factor":[260],"affecting":[261],"SMC's":[263],"reimbursement":[264]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}